Malvern, PA, March 29, 2017 — Center Point Clinical Services, creator of the world’s first Siteless CRO platform, announced today that its poster titled Evaluating frequency and cost impact of pharmacist interventions in phase 3 clinical trials for patients with sub optimally controlled diabetes won a silver ribbon at the Academy of Managed Care Pharmacy, #AMCP2017, Managed Care and Specialty Pharmacy annual meeting in Denver, Colorado.

Joe Martinez, CEO of Center Point Clinical Services and the lead author of the poster said, “We are honored to have been recognized by AMCP’s prestigious judging committee. The silver ribbon further validates the important work and contribution that pharmacists make on a daily basis in helping to modernize and strengthen the clinical trial process. Regular pharmacist interaction with clinical study patients has repeatedly shown to improve patient compliance and adherence and in turn, save sponsor companies not only time and money in the long term development of a drug but also strengthen the reliability of their data.”

Center Point’s silver ribbon poster explores the impact of pharmacist interventions on medication adherence and adverse events in clinical trials focusing on diabetes. Pharmacists called study participants in trials focused on diabetes at speciﬁc time-points during the trials. The pharmacist call was in addition to the normal monitoring provided by the clinical trial site staff. During each call, the number and types of interventions were documented. Descriptive statistics (frequencies) and stratiﬁcation by cost impact were performed to determine the number and type of interventions by call and by patient across 2 NiGLM Drug A and Drug B studies.

A total of 25, 829 calls were made. Of these calls, 11,765 calls had at least one intervention involving 3,573 patients (92.3%). The most frequent interventions were regarding adverse events, protocol violations for medication usage, concurrent medications, etc. The greatest number of interventions pertained to high cost, serious, adverse events that could have had a negative impact on the trial’s outcomes data.

Center Point Clinical Services LLC. is a specialty, site-less, technology contract research organization (CRO) that helps pharmaceutical, biotech, and medical device companies successfully reach their regulatory and commercialization goals in less time and at a lower cost than competitors. The company’s evolutionary Site-less CRO model helps to recruit patients faster, identify and address patient issues in real-time and complete trials within time and cost projections. The company offers two premier signature services. The first is the Clinical Trial Research Pharmacist (CTRP®) program, which uses only licensed, specially trained pharmacists to communicate with patients. Center Point is the only CRO to offer such a unique and effective service. CTRP has repeatedly demonstrated improved patient retention, medication compliance and overall outcomes in clinical trials. The second service includes a series of practical signature study solutions intended to support regulatory and commercialization goals. These include: real world evidence (RWE) analysis and publications, health economic outcomes and research (HEOR), market access and reimbursement support, industry standard quality metrics data, and scientific publications. For more information please visit www.centerpointclinicalservices.com